D. E. Shaw & Co., Inc. Adma Biologics, Inc. Transaction History

D. E. Shaw & Co., Inc.

$122 Billion
Q4 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Adma Biologics, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 3,066,575 shares of ADMA stock, worth $62.1 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

3,066,575

Previous 5,264,095 41.75%

Holding current value

$62.1 Million

Previous $105 Million 50.02%

% of portfolio

0.04%

Previous 0.1%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$15.62 - $22.62 $34.3 Million - $49.7 Million	-2,197,520 Reduced 41.75%	3,066,575 $52.6 Million
Q3 2024 Nov 14, 2024	SELL	$11.21 - $20.03 $17.5 Million - $31.3 Million	-1,560,422 Reduced 22.86%	5,264,095 $105 Million
Q2 2024 Aug 14, 2024	BUY	$5.98 - $11.18 $8.63 Million - $16.1 Million	1,442,799 Added 26.81%	6,824,517 $76.3 Million
Q1 2024 May 15, 2024	SELL	$4.4 - $6.74 $4.98 Million - $7.63 Million	-1,131,835 Reduced 17.38%	5,381,718 $35.5 Million
Q4 2023 Feb 14, 2024	SELL	$3.08 - $4.52 $3.26 Million - $4.78 Million	-1,058,140 Reduced 13.97%	6,513,553 $29.4 Million
Q3 2023 Nov 14, 2023	SELL	$3.47 - $4.61 $2.09 Million - $2.78 Million	-602,124 Reduced 7.37%	7,571,693 $27.1 Million
Q2 2023 Aug 14, 2023	SELL	$3.12 - $4.22 $117,798 - $159,330	-37,756 Reduced 0.46%	8,173,817 $30.2 Million
Q1 2023 May 15, 2023	SELL	$3.01 - $3.87 $893,476 - $1.15 Million	-296,836 Reduced 3.49%	8,211,573 $27.2 Million
Q4 2022 Feb 14, 2023	BUY	$2.47 - $3.88 $6.58 Million - $10.3 Million	2,664,613 Added 45.6%	8,508,409 $33 Million
Q3 2022 Nov 14, 2022	BUY	$2.03 - $2.86 $2.05 Million - $2.89 Million	1,011,404 Added 20.93%	5,843,796 $14.2 Million
Q2 2022 Aug 15, 2022	BUY	$1.43 - $2.2 $4.19 Million - $6.45 Million	2,930,104 Added 154.03%	4,832,392 $9.57 Million
Q1 2022 May 16, 2022	BUY	$1.28 - $1.83 $2.32 Million - $3.32 Million	1,812,981 Added 2030.05%	1,902,288 $3.48 Million
Q4 2021 Feb 14, 2022	BUY	$1.09 - $1.66 $97,344 - $148,249	89,307 New	89,307 $126,000
Q3 2021 Nov 15, 2021	SELL	$1.13 - $1.65 $239,211 - $349,291	-211,692 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$1.51 - $2.07 $319,654 - $438,202	211,692 New	211,692 $339,000
Q4 2020 Feb 16, 2021	SELL	$1.8 - $2.56 $18,054 - $25,676	-10,030 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$2.04 - $3.74 $20,461 - $37,512	10,030 New	10,030 $24,000

Others Institutions Holding ADMA

# of Institutions

338

Shares Held

182M

Call Options Held

1.72M

Put Options Held

846K

View Full List

About ADMA BIOLOGICS, INC.

Ticker ADMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 196,356,992
Market Cap $3.98B
Description
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...

More about ADMA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account